Literature DB >> 22240716

Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Jamil Ahsan Kazi1.   

Abstract

Nocistatin and nociceptin/orphanin FQ (N/OFQ) are two neuropeptides which may have opposite effects in several biological functions but their neuro-anatomical sites of interaction are not fully clear. We investigated interaction between the effect of intracerebroventricular (i.c.v.) injection of nocistatin and N/OFQ, on c-Fos expression in the mouse thalamus, using c-Fos immunohistochemistry. We found that co-injection of nocistatin with N/OFQ significantly modulates c-Fos expression in the thalamus. The present study strongly suggests that "Nocistatin-Nociceptin" interaction system in the thalamus may be the promising neuromodulatory sites in the investigation of unlocking their possible therapeutic circuit in nociception, memory and anxiety.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240716     DOI: 10.1007/s10072-012-0933-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  39 in total

Review 1.  Thalamic organization and function after Cajal.

Authors:  Edward G Jones
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

2.  Pathways for fear perception: modulation of amygdala activity by thalamo-cortical systems.

Authors:  Pritha Das; Andrew H Kemp; Belinda J Liddell; Kerri J Brown; Gloria Olivieri; Anthony Peduto; Evian Gordon; Leanne M Williams
Journal:  Neuroimage       Date:  2005-05-15       Impact factor: 6.556

3.  Supraspinal nocistatin and its amide derivative antagonize the hyperalgesic effects of nociceptin in mice.

Authors:  Eugene Hern C Liu; Yuji Nishiuchi; Terutoshi Kimura; Shinro Tachibana
Journal:  Neurosci Lett       Date:  2005-12-27       Impact factor: 3.046

Review 4.  Neuroanatomy of the pain system and of the pathways that modulate pain.

Authors:  W D Willis; K N Westlund
Journal:  J Clin Neurophysiol       Date:  1997-01       Impact factor: 2.177

Review 5.  The induction of pain: an integrative review.

Authors:  M J Millan
Journal:  Prog Neurobiol       Date:  1999-01       Impact factor: 11.685

6.  Fos imaging reveals that lesions of the anterior thalamic nuclei produce widespread limbic hypoactivity in rats.

Authors:  Trisha A Jenkins; Rebecca Dias; Eman Amin; Malcolm W Brown; John P Aggleton
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

7.  Recall of emotional states in posttraumatic stress disorder: an fMRI investigation.

Authors:  Ruth A Lanius; Peter C Williamson; James Hopper; Maria Densmore; Kristine Boksman; Madhulika A Gupta; Robert W J Neufeld; Joseph S Gati; Ravi S Menon
Journal:  Biol Psychiatry       Date:  2003-02-01       Impact factor: 13.382

8.  Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.

Authors:  Elaine C Gavioli; Giles A Rae; Girolamo Calo'; Remo Guerrini; Thereza C M De Lima
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Effects of nociceptin on the exploratory behavior of mice in the hole-board test.

Authors:  Junzo Kamei; Yasuhiro Matsunawa; Shigeo Miyata; Shun-ichi Tanaka; Akiyoshi Saitoh
Journal:  Eur J Pharmacol       Date:  2004-04-05       Impact factor: 4.432

10.  Patterns of colocalization of neuronal nitric oxide synthase and somatostatin-like immunoreactivity in the mouse hippocampus: quantitative analysis with optical disector.

Authors:  S Jinno; T Kosaka
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  1 in total

Review 1.  Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.

Authors:  Jong Yung Park; Suji Chae; Chang Seop Kim; Yoon Jae Kim; Hyun Joo Yi; Eunjoo Han; Youngshin Joo; Surim Hong; Jae Won Yun; Hyojung Kim; Kyung Ho Shin
Journal:  Korean J Physiol Pharmacol       Date:  2019-10-24       Impact factor: 2.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.